logo

Arena Pharmaceutical Inc. (ARNA)



Trade ARNA now with
  Date
  Headline
2/26/2020 4:03:23 PM Arena Pharma Q4 Loss/share $1.76 Vs. Profit $1.35 Year Ago
1/16/2020 9:03:13 AM FDA Grants Fast Track Designation To Arena' APD418 For Development In Decompensated Heart Failure Patients
1/13/2020 4:10:48 PM Arena Pharmaceuticals Appoints Joan Schmidt As EVP, General Counsel And Secretary
1/2/2020 8:32:36 AM Arena Pharma And Beacon Discovery Expand Partnership To Focus On Multiple Immune And Inflammatory Targets
11/7/2019 4:05:05 PM Arena Pharma Q3 Loss/share $1.46 Vs. Loss $0.70 Year Ago
11/6/2019 8:35:01 AM Arena Presents New Data Highlighting Human Mass Balance And Metabolism Profile Of Etrasimod
10/28/2019 8:31:59 AM Arena Pharmaceuticals Says First Subject Dosed In Phase 2 ADVISE Trial Evaluating Etrasimod
10/18/2019 3:09:26 AM Arena Pharma To Present New Open-label Extension Data From Phase 2 OASIS Trial For Etrasimod At UEG Week
9/26/2019 8:38:40 AM Arena Pharmaceuticals Presents New Data From Phase 2 OASIS Trial For Etrasimod
9/9/2019 8:32:36 AM Arena Presents New Patient-Reported Outcomes Data For Olorinab
8/7/2019 4:04:54 PM Arena Q2 Loss Per Share Of $1.24 Vs. $0.65 Last Year
7/25/2019 8:32:24 AM Arena Says First Subject Dosed In Phase 2 CAPTIVATE Trial Evaluating Olorinab
  
 
>